A Study in Healthy Volunteers to Compare the Pharmacokinetics of Sotorasib Administered as 1 or 2 Tablets

PHASE1CompletedINTERVENTIONAL
Enrollment

146

Participants

Timeline

Start Date

March 21, 2022

Primary Completion Date

July 17, 2022

Study Completion Date

July 17, 2022

Conditions
Healthy Participants
Interventions
DRUG

Sotorasib

Oral Tablet

Trial Locations (4)

32117-5116

Labcorp Clinical Research Unit - Daytona Beach, Daytona Beach

33143-5026

Miami Research Associates LLC - Main Campus / Late Phase, South Miami

75247-4989

Labcorp Clinical Research Unit - Dallas, Dallas

53704-2526

Labcorp Clinical Research Unit - Madison, Madison

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY

NCT05327491 - A Study in Healthy Volunteers to Compare the Pharmacokinetics of Sotorasib Administered as 1 or 2 Tablets | Biotech Hunter | Biotech Hunter